Merck KGaA

This is the limited version of the Merck KGaA company profile: Join LinkedIn or Sign In to see more information.

Merck Kommanditgesellschaft auf Aktien develops, manufactures, and markets pharmaceutical products and laboratory chemicals worldwide. The Merck Serono division primarily offers various prescription drugs, including Erbitux for metastatic colorectal, head, and neck cancer; UFT for colorectal cancer; Rebif for multiple sclerosis; Gonal-f Ovitrelle Pergoveris, Luveris, Crinone, and Cetrotide for infertility; Saizen for growth hormone disorders; Serostim for HIV-associated wasting; the Glucophage family for type 2 diabetes; the Concor family for cardiovascular diseases; Euthyrox for thyroid disorders; Raptiva for psoriasis; and Cyanokit for cyanide poisoning. The Consumer Health Care division offers over-the-counter products for preventive health care and self-treatment of minor ailments. Its product portfolio includes products to strengthen the joints under the Seven Seas brand; the vitamin products Cebion, Bion 3 (Multibionta), and Diabion for everyday health protection; Femibion and Kidabion health brands for women and children; and Nasivin, a cold remedy. The Liquid Crystals division offers liquid crystals and mixtures for use in LCD televisions, computer monitors, notebooks, digital cameras, mobile phones, PDAs, MP3 players, and various other displays. The Performance and Life Science Chemicals division supplies reagents for analysis and other applications; various products for analytical chromatography, microbiology, and food and environmental analysis; and a range of solvents, salts, acids, alkalis, and organic chemicals. It also offers separation and purification materials; ionic liquids; active ingredients used in pharmaceuticals, cosmetics, and sunscreen and skin care products; active ingredients for food supplements; biological crop-enhancing technologies in crop bioscience; and products for technical applications, as well as pigments for various applications. The company was founded in 1668 and is headquartered in Darmstadt, Germany.

Your Connections to Merck KGaA

To see how you’re connected: Join Now or Sign In

New Hires and Recent Promotions at Merck KGaA

What’s this?
  • Christoph Hüls, Vice President Operational Excellence R&D

    was CEO at Protagen AG - 5 months ago

  • Stefan Meyer, Portfolio Manger Oncology

    was Portfolio Manager at Medical Strategy - last month

  • Mark Laing, NPD Seven Seas at Merck KGaA

    was R&D Director at Danone - 4 months ago

  • Uwe Fischbeck, Corporate Master Black Belt

    was Master Black Belt and Continuous Improvement Champion at Alcan - this month

  • Tord Helenius, Senior Director

    was Director of the CIO Office, Organon at Organon - 5 months ago

  • Volker Hilarius, Director Innovation Scouting

    was Director Licensing - 2 months ago

  • Michael Sandmann, Project Manager R&D Information Systems

    was Project Manager - 2 months ago

  • Eric Nowee, Consultant

    was IT Consultant - this month

  • Pablo Maldonado, Stream Lead and BPDO SAP FI (Contractor)

    was BPDO SAP FI (Contractor) - 3 months ago

  • Margarita Wuchrer, Head of Laboratory at Merck Serono

    was Head of Laborytory at Merck Serono - last month

To see more new hires & promotions: Join Now or Sign In

Stock Information about Merck KGaA

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com Copyright © 2008 Capital IQ

This LinkedIn Company Profile was created by LinkedIn and is about Merck KGaA. This page is not endorsed by or affiliated with Merck KGaA. For questions regarding LinkedIn Company Profiles,

Merck KGaA (MRK) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions